Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost eye drops in thyroid eye disease: randomized crossover trial
2014-000540-15Phase 4Completed
- Sponsor
- Cardiff University
- Start
- Apr 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of bimatoprost in Graves Orbitopathy (GO) and Graves' ophthalmopathy (TED) (2 arms), sponsored by Cardiff University. Primary endpoint: Change in exophthalmometry readings. Started Apr 2014; status: completed.
02
Drugs
bimatoprost
03
Conditions
Graves Orbitopathy (GO)Graves' ophthalmopathy (TED)
Beyond the preview
Go deeper on 2014-000540-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-000540-15.